The global urodynamic equipment and consumables market size was estimated at USD 189.15 million in 2016 and is anticipated to grow at a CAGR of 6.32% throughout the forecast period. The market is predominantly driven by rising prevalence of diseases such as benign prostatic hypertrophy, bladder cancer, neurogenic bladder dysfunction, overactive bladder, and others.
According to the World Health Organization, globally, 330,000 new cases of bladder cancer are diagnosed every year. In addition, as per National Association for Incontinence, 200 million people globally are suffering from urinary incontinence, which raises the clinical urgency to adopt urodynamic equipment.
U.S. urodynamic equipment and consumables market by type, 2014 - 2025 (USD Million)
Increase in healthcare initiatives being undertaken to create awareness about urological problems and available diagnostics &treatment is anticipated to broaden growth potential. For instance, “Let’s Talk and Think About Continence” (Japan), “Continence Awareness Week” (Continence Foundation, UK), and others.
As a result of these initiatives, an increasing number of people suffering from urinary incontinence have been able to overcome the social stigma associated with it and have begun consulting physicians. This has thereby fueled demand for these medical devices.
Technological advancements, such as doppler ultrasound video urodynamic, condom catheter, intravesical prostatic protrusion, and penile cuff, are also amongst major growth contributors. In addition, continuous product approvals, a proliferating network of testing centers, and availability of medical reimbursement for urological preliminary tests are also responsible for propelling the urodynamic equipment and consumables market.
In 2016, the uroflowmetry segment dominated the type segment with a share of over 30.0%. The substantial share registered by this segment is a result of extensive usage of uroflowmetry in the diagnosis of urinary blockage, benign prostatic hypertrophy, bladder cancer, neurogenic bladder, bladder dysfunction, and prostate cancer.
Due to innovative technology, uroflowmetry products give accurate results. As a result, there is a significant increase in adoption rates amongst physicians. In addition, increasing global presence of manufacturers owing to expanding distribution networks results in greater access to these products, which is also a key contributing factor.
Ambulatory systems are expected to exhibit a strong CAGR of over 7.0% throughout the forecast period. The exponential growth of this segment can be attributed to the associated benefits of ambulatory systems. These benefits include greater portability, affordability, and real-time diagnosis to yield highly accurate results.
Electromyographs (EMGs) are anticipated to grow moderately during the forecast period. These devices find application in a wide range of disorders, such as muscular dystrophy, myasthenia gravis, radiculopathies, carpal tunnel syndrome, amyotrophic lateral sclerosis, sciatica, and many others. EMG has various diagnostic and research applications. EMG is also used to avoid postoperative residual curarization (PORC) and conduct nerve conduction studies.
In 2016, North America accounted for the largest share of over 37.0% amongst all regions. This can be attributed to rising prevalence of target diseases. The dominant share is also a consequence of high adoption rate of urodynamic products in various diagnostic, healthcare, & pharmaceutical centers and growing preference of urogynecologists & urologists for urodynamic tests.
Global urodynamic equipment and consumables market share by region, 2016 (%)
Asia Pacific is expected to witness an exponential CAGR of over 6.0% throughout the forecast period. This growth can be attributed to a rise in the prevalence of urological diseases, growing disposable income, and unmet patient needs. Rapid rise in geriatric population, which has greater vulnerability to urological dysfunctions, is expected to further contribute to the market growth across this region.
Another factor expected to contribute to growth in Asia Pacific is increasing availability and usage in diagnostic centers. In addition, rapid economic growth in developing countries such as India, Singapore, and China others are also anticipated to boost product penetration.
The highly competitive environment is a result of key players extensively deploying sustainability strategies. These include Boston Scientific Corporation; LABORIE; Verathon, Inc.; and others. These companies are consistently striving to implement strategies such as mergers & acquisitions, new product development initiatives, and geographical expansion.
For instance, in March 2017, LABORIE acquired ANDROMEDA Medizinische Systems GmbH to expand its product offerings in Europe. Similarly, in November 2016, Boston Scientific Corporation launched Dakota Nitinol Stone Retrieval Device with OpenSure Handle to expand its product portfolio.
Attribute |
Details |
Base year for estimation |
2016 |
Actual estimates/Historical data |
2014 - 2016 |
Forecast period |
2017 - 2025 |
Market representation |
Revenue in USD Million and CAGR from 2017 to 2025 |
Regional scope |
North America, Europe, Asia Pacific, Latin America, Middle East & Africa |
Country scope |
U.S., Canada, Germany, UK, Japan, China, India, Brazil, Mexico, South Africa |
Report coverage |
Revenue forecast, company share, competitive landscape, growth factors, and trends |
15% free customization scope (equivalent to 5 analyst working days) |
If you need specific market information, which is not currently within the scope of the report, we will provide it to you as a part of customization |
This report forecasts revenue growth at global, regional, & country levels and provides an analysis on the industry trends in each of the sub-segments from 2014 to 2025. For the purpose of this study, Grand View Research has segmented the global urodynamic equipment and consumables market on the basis of type and region:
Type Outlook (Revenue, USD Million, 2014 - 2025)
Uroflowmetry Equipment
Cystometry
Ambulatory Urodynamic Systems
Electromyographs
Video Urodynamic Systems
Urodynamic Consumables
Urodynamic Catheters
Urodynamic Pumps and Transducer Sets
Regional Outlook (Revenue, USD Million, 2014 - 2025)
North America
The U.S.
Canada
Europe
Germany
The U.K.
Asia Pacific
Japan
China
India
Latin America
Brazil
Mexico
Middle East & Africa
South Africa
This report has a service guarantee. We stand by our report quality.
We are in compliance with GDPR & CCPR norms. All interactions are confidential.
Design an exclusive study to serve your research needs.
Get your queries resolved from an industry expert.
"The quality of research they have done for us has been excellent..."
With Covid-19 infections rising globally, the apprehension regarding a shortage of essential life-saving devices and other essential medical supplies in order to prevent the spread of this pandemic and provide optimum care to the infected also widens. In addition, till a pharmacological treatment is developed, ventilators act as a vital treatment preference for the COVID-19 patients, who may require critical care. Moreover, there is an urgent need for a rapid acceleration in the manufacturing process for a wide range of test-kits (antibody tests, self-administered, and others). The report will account for Covid19 as a key market contributor.